Squarepoint’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.92M | Buy |
+700,153
| New | +$2.22M | ﹤0.01% | 2206 |
|
|
2025
Q4 | – | Sell |
-296,811
| Closed | -$787K | – | 4462 |
|
|
2025
Q3 | $787K | Buy |
296,811
+82,425
| +38% | +$159K | ﹤0.01% | 2880 |
|
|
2025
Q2 | $211K | Sell |
214,386
-663,022
| -76% | -$664K | ﹤0.01% | 3949 |
|
|
2025
Q1 | $1.26M | Buy |
877,408
+538,376
| +159% | +$992K | ﹤0.01% | 2462 |
|
|
2024
Q4 | $746K | Buy |
339,032
+128,810
| +61% | +$301K | ﹤0.01% | 3344 |
|
|
2024
Q3 | $347K | Buy |
+210,222
| New | +$424K | ﹤0.01% | 3358 |
|
|
2024
Q2 | – | Sell |
-300,300
| Closed | -$805K | – | 4238 |
|
|
2024
Q1 | $805K | Buy |
300,300
+212,588
| +242% | +$517K | ﹤0.01% | 2740 |
|
|
2023
Q4 | $262K | Buy |
87,712
+59,743
| +214% | +$77.5K | ﹤0.01% | 3442 |
|
|
2023
Q3 | $27.4K | Buy |
+27,969
| New | +$40.5K | ﹤0.01% | 3681 |
|
|
2023
Q2 | – | Sell |
-184,941
| Closed | -$294K | – | 3685 |
|
|
2023
Q1 | $294K | Buy |
184,941
+53,405
| +41% | +$276K | ﹤0.01% | 2584 |
|
|
2022
Q4 | $819K | Buy |
131,536
+73,674
| +127% | +$527K | 0.01% | 1967 |
|
|
2022
Q3 | $388K | Buy |
57,862
+9,797
| +20% | +$67.3K | ﹤0.01% | 2333 |
|
|
2022
Q2 | $306K | Buy |
+48,065
| New | +$273K | ﹤0.01% | 2280 |
|
|
2022
Q1 | – | Sell |
-72,352
| Closed | -$362K | – | 3026 |
|
|
2021
Q4 | $362K | Sell |
72,352
-147
| -0.2% | -$1.18K | ﹤0.01% | 2347 |
|
|
2021
Q3 | $874K | Buy |
72,499
+33,263
| +85% | +$484K | 0.01% | 1640 |
|
|
2021
Q2 | $830K | Buy |
39,236
+19,691
| +101% | +$474K | 0.01% | 1772 |
|
|
2021
Q1 | $548K | Buy |
19,545
+4,436
| +29% | +$131K | 0.01% | 1948 |
|
|
2020
Q4 | $393K | Buy |
+15,109
| New | +$453K | ﹤0.01% | 2002 |
|
|
2020
Q1 | – | Sell |
-27,480
| Closed | -$1.64M | – | 2040 |
|
|
2019
Q4 | $1.64M | Sell |
27,480
-2,012
| -7% | -$90.5K | 0.01% | 1028 |
|
|
2019
Q3 | $1.08M | Buy |
29,492
+9,092
| +45% | +$360K | 0.01% | 1181 |
|
|
2019
Q2 | $949K | Sell |
20,400
-15,643
| -43% | -$735K | 0.01% | 1286 |
|
|
2019
Q1 | $1.45M | Buy |
36,043
+18,861
| +110% | +$846K | 0.02% | 913 |
|
|
2018
Q4 | $790K | Sell |
17,182
-11,626
| -40% | -$560K | 0.01% | 1023 |
|
|
2018
Q3 | $1.28M | Sell |
28,808
-13,940
| -33% | -$640K | 0.02% | 884 |
|
|
2018
Q2 | $1.68M | Buy |
42,748
+23,862
| +126% | +$1.21M | 0.02% | 693 |
|
|
2018
Q1 | $1.37M | Buy |
18,886
+8,561
| +83% | +$629K | 0.02% | 696 |
|
|
2017
Q4 | $680K | Buy |
+10,325
| New | +$556K | 0.01% | 1012 |
|
|
2017
Q2 | – | Sell |
-7,826
| Closed | -$276K | – | 1599 |
|
|
2017
Q1 | $276K | Sell |
7,826
-2,751
| -26% | -$63K | 0.01% | 1125 |
|
|
2016
Q4 | $132K | Buy |
+10,577
| New | +$126K | 0.01% | 1575 |
|
|
2016
Q2 | – | Sell |
-41,600
| Closed | -$703K | – | 1173 |
|
|
2016
Q1 | $703K | Buy |
+41,600
| New | +$669K | 0.05% | 488 |
|
|
2015
Q3 | – | Sell |
-5,000
| Closed | -$409K | – | 462 |
|
|
2015
Q2 | $409K | Buy |
+5,000
| New | +$489K | 0.13% | 235 |
|
Other funds holding ESPR
WA
TSC
O
VCM
